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Abstract
Background: Primary human airway epithelial cells cultured in an air-liquid interface (ALI) develop a well-differentiated
epithelium. However, neither characterization of mucociliar differentiation overtime nor the inflammatory function of
reconstituted nasal polyp (NP) epithelia have been described.
Objectives: 1st) To develop and characterize the mucociliar differentiation overtime of human epithelial cells of chronic
rhinosinusitis with nasal polyps (CRSwNP) in ALI culture system; 2nd) To corroborate that 3D in vitro model of NP
reconstituted epithelium maintains, compared to control nasal mucosa (NM), an inflammatory function.
Methods: Epithelial cells were obtained from 9 NP and 7 control NM, and differentiated in ALI culture for 28 days.
Mucociliary differentiation was characterized at different times (0, 7, 14, 21, and 28 days) using ultrastructure analysis by
electron microscopy; DNp63 (basal stem/progenitor cell), b-tubulin IV (cilia), and MUC5AC (goblet cell) expression by
immunocytochemistry; and mucous (MUC5AC, MUC5B) and serous (Lactoferrin) secretion by ELISA. Inflammatory function
of ALI cultures (at days 0, 14, and 28) through cytokine (IL-8, IL-1b, IL-6, IL-10, TNF-a, and IL-12p70) and chemokine (RANTES,
MIG, MCP-1, IP-10, eotaxin-1, and GM-CSF) production was analysed by CBA (Cytometric Bead Array).
Results: In both NP and control NM ALI cultures, pseudostratified epithelium with ciliated, mucus-secreting, and basal cells
were observed by electron microscopy at days 14 and 28. Displaying epithelial cell re-differentation, b-tubulin IV and
MUC5AC positive cells increased, while DNp63 positive cells decreased overtime. No significant differences were found
overtime in MUC5AC, MUC5B, and lactoferrin secretions between both ALI cultures. IL-8 and GM-CSF were significantly
increased in NP compared to control NM regenerated epithelia.
Conclusion: Reconstituted epithelia from human NP epithelial cells cultured in ALI system provides a 3D in vitro model that
could be useful both for studying the role of epithelium in CRSwNP while developing new therapeutic strategies, including
cell therapy, for CRSwNP.
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Introduction
The mucosa of the nose and paranasal sinuses is lined by a
pseudostratified epithelium, formed by ciliated and non-ciliated
columnar cells, goblet cells and basal cells [1,2]. This epithelium
plays a crucial role in maintaining the homeostasis of both nasal
and sinonasal mucosa. It is the first line of host defense against
inhaled pollutants, allergens, and microbial pathogens [3,4], it
regulates not only innate but also acquired immunity through
production of a wide range of cytokines, chemokines, and
mediators [5,6], and it is also able to repair and remodel its
structure and integrity after epithelial damage [2,7]. However,
when nasal and sinonasal mucosa are chronically inflamed, such as
in chronic rhinosinusitis with nasal polyps (CRSwNP), the
epithelium function and structure become altered [1,2].
CRSwNP is a disease of unknown etiology, characterized by a
persistent symptomatic inflammation of the nasal and sinonasal
mucosa [1]. In patients with CRSwNP, the epithelium is damaged
(partial shedding, complete denudation, or loss of cilia) and shows
an abnormal remodeling (goblet cell hyperplasia, basal cell
hyperplasia, or metaplasia) [2,8]. As a consequence, the identifi-
cation of molecular mechanisms of the upper airway epithelial
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cells involved in repair, proliferation, and mucociliary differenti-
ation under normal and pathological conditions, offers some
potential for the development of new strategies for CRSwNP
treatment.
A number of in vitro methods have been previously developed to
investigate the nasal epithelium biology and physiopathology in
human airways [9–11]. The human nasal RPMI-2650 cell line,
derived from squamous cell carcinoma of nasal septum, are widely
used as an in vitro cell culture system due to are easily maintained
in culture, has extended lifespan, improved proliferation and
homogeneity [12,13], but they do not have the morphology,
biochemical characteristics, and cellular response of control nasal
epithelial cells [11]. On the other hand, primary cells cultured in
submerged culture, clearly undergo a dedifferentiation and loss of
the original in vivo phenotype [9,14]. An ideal human nasal
epithelium in vitro model would require a morphologically well
differentiated culture, with ciliated, non-ciliated, secretory, and
basal cells, while showing epithelial function (barrier formation,
mucus secretion, ciliary activity, cytokines and chemokines
signalling) [10,11]. These requirements are only present in the
following in vitro culture systems: organotypic explant culture or
primary cells cultured at the air-liquid interface (ALI). The former
maintain the original epithelium whereas the latter mimic the
epithelium. Organotypic explants are ex vivo models of nasal
mucosa that can be cultured maintaining intact the original
epithelium. In fact, they have been widely used to study the human
normal [15,16,17] and diseased [18] nasal mucosa. However, due
to presence of numerous cell types, matrices, and other
environmental factors, explant culture models are less homoge-
neous, standarized, and reproducible than ALI culture models for
primary epithelial cells (Table 1). It is well-known that the ALI
system provides a well differentiated culture that has been
developed in both human upper [19–23] and lower [19,24–29]
airways, as well as in different animals [30–32]. Human nasal
epithelial cells cultured in an ALI system represent the most
promising experimental tool for investigating repair and differen-
tiation, as well as to perform pharmacological, toxicological, and
transport studies [11,25,28,33].
Mucociliary differentiation in ALI culture models has been
described with human nasal epithelial cells from inferior turbinates
[19,22,23], and nasal polyps (NP) [20,21]. Concerning to NP,
studies from Bleier et al. [20] and Hajj et al. [21] described that it
is possible to regenerate NP epithelium by culturing isolated
epithelial or adult basal cells from NP at the ALI culture system,
respectively. The former study demonstrated that NP reconstituted
epithelium retained their primary phenotype with respect to ciliary
function and epithelial permeability, whereas the latter study
provided evidence that restored epithelium was differentiated and
showing intact immune barrier functions by secreting factors that
kill bacteria. However, neither characterization of mucociliar
differentiation over time of NP epithelial cells in ALI cultures, nor
the inflammatory function of NP reconstituted epithelia, have
been described.
Therefore, the aims of this study were to develop and
characterize the mucociliary differentiation over time of NP
epithelial cells cultured at the ALI culture, and to validate the
inflammatory function of the in vitro NP reconstituted epithelia by
measuring their cytokine and chemokine secretions, in comparison
to control nasal mucosa (NM).
Materials and Methods
Ethics Statement
All patients signed informed consent to participate in the study,
which was approved by our institution’s Scientific and Ethics
Committee:
N Name of approval committee: Ethics Committee for Clinical
Research, Hospital Clı´nic, University of Barcelona.
N Date on which approval was given: 12/04/2012.
N Document number of approval: 2012\7466.
Study Population
Nasal polyp specimens (N = 9) were obtained from patients
undergoing endoscopic sinus surgery for severe CRSwNP, a
negative skin prick test to common allergens, and without
Figure 1. Ultrastructural study of apical surfaces in ALI cultures from both nasal polyp and control nasal mucosa at different days
by scanning electron microscopy. At day 0 (left column), representative images are showing apical surfaces without ciliated cells. At days 14
(centre column) and 28 (right column), apical surfaces showing ciliated cells.
doi:10.1371/journal.pone.0100537.g001
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Table 1. Comparison between 3D in vitro model of reconstituted epithelium and organotypic explant culture.
Straight Tissue
Culture/Sections
of Tissue
3D In Vitro
Reconstituted Epithelium
Maintain Original Epithelium Yes No
(but similar)
Different Tissue
Structures and/or Cells
Yes No
(Heterogeneity) (tissue section)
Infiltrated Inflammatory Cells Yes No
Controlled Environment Yes Yes
Experimental Studies
within Epithelium
Yes Yes
(with pro-inflammatory,
anti-inflammatory, and other
mediators, mucociliar differentiation…)
(non-specific)
Test Drugs in Epithelium Yes Yes
(Effects, Toxicity, and their
Transepithelial Transport)
(non-specific)
Functional Genetic Studies No Yes
(Gene/small RNAs
Transfection/Transduction,
Gene Silencing…)
Study of Mucous and
Serous Secretions
from the Epithelium
Yes Yes
(basal, induced, or inhibited) (but altered by glands)
Study of Cytokine
and Chemokine
Secretion from
the Epithelium
Yes Yes
(basal, induced, or inhibited) (non-specific due
to inflammatory and
other cells)
doi:10.1371/journal.pone.0100537.t001
Figure 2. Ultrastructural study in ALI cultures from both nasal polyp and control nasal mucosa at different days by transmission
electron microscopy. At day 0 (left column), representative images are showing desmosomes (arrowheads), interdigitations (asteriks). At day 14
(centre column), ciliated (C), goblet (G) and basal (B) cells. At day 28 (right column), longitudinal sections of motile cilia (upper) and secretory granules
of a goblet cell (lower).
doi:10.1371/journal.pone.0100537.g002
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bronchial asthma or aspirin intolerance. The clinical diagnosis of
CRSwNP was based on nasal symptoms, presence of nasal polyp
by nasal endoscopy, and bilateral sinus opacification detection by
computed tomography scan, following EPOS criteria [1]. Patients
with cystic fibrosis were excluded from the study.
Control nasal mucosa specimens (n = 7) were obtained from
inferior turbinates of subjects undergoing septoplasty or partial
turbinectomy. All subjects with negative skin prick test to common
allergens, without bronchial asthma or aspirin intolerance.
None of the patients and subjects involved in the study had had
an upper respiratory tract infection within 2 weeks prior to
surgery. Neither were they undergoing topical or systemic
corticosteroid treatment during the 4 weeks leading up to surgery.
Tissue Handling and Epithelial Cell Isolation from the
Explant Culture
Tissue specimens were surgically removed and immediately
transported to laboratory in sterile growth medium composed of
BEBM (Bronchial Epithelial Cell Basal Medium; Clonetics, Lonza
Group Ltd, Switzerland) supplemented with Epidermal Growth
Factor (25 ng/ml), Hydrocortisone (0.5 mg/ml), Epinephrine
(0.5 mg/ml), Transferrin (10 mg/ml), Insulin (5 mg/ml), Triiodo-
thyronine (6.5 mg/ml), all-trans retinoic acid (50 nM), Bovine
Pituitary Extract (52 mg/ml), Gentamicin (30 mg/ml), and Am-
photericin B (15 ng/ml), all included in the SingleQuots Kit
purchased by Clonetics (Lonza), with the exception of human
recombinant epidermal growth factor and all-trans retinoic acid
that were purchased by Sigma-Aldrich Co (St. Louis, MO, USA).
Figure 3. Re-differentation over time of human nasal epithelial cells from both nasal polyp and control nasal mucosa in ALI
cultures. A, Pie charts, with modeled size relative to total cell number, are representing the percentage of different cell phenotypes over time. B,
table shows the total number of cells and percentages of cell phenotypes from both cultures types. Total and positive cells were counted in three
wells (5 fields from different areas of each well at 400x magnification) from different nasal polyp (NP, n = 3) and control nasal mucosa (NM, n = 3) ALI
cultures and the results were subsequently averaged. *, P,0.05 vs day 0. The nonparametric Wilcoxon Signed-Ranks Test and Mann-Whitney U test
were used for paired comparisons and between-group comparisons respectively. Statistical significance was set at P,0.05.
doi:10.1371/journal.pone.0100537.g003
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Primary cultures of human nasal epithelial cells were obtained
from the explant method as previously outlined [34,35,36]. Briefly,
tissue explants were carefully dissected away from the mucosal
surface of tissue specimens by using sterile surgical material. Size
of explants obtained was of approximately 20–30 mm2. Small
explants were washed three times with fresh, sterile media, in
order to remove blood and mucous when was present. Then, tissue
explants were plated on 6-well plates coated with rat tail collagen
type I (Sigma-Aldrich), always orientated with the epithelial layer
to be in contact with the collagen-coated culture plates. A single
drop of growth medium was added directly on to the tissue to
allow the tissue to adhere to the plate. Once the tissue was
adherent, more media was added slowly (in order not to dislodge
the tissue). Explant culture was performed in a 5% CO2
humidified atmosphere at 37uC, with the culture media being
changed daily. Cell growth from explants usually started from day
3 to day 7 (see Figure S1).
To demonstrate the purity of epithelial cells obtained from both
NP and control NM explants, the cells were trypsinized using the
Subculture Reagent Pack (Lonza). Cytospin slide preparations
were fixed in acetone for 15 minutes, and processed for
immunofluorescent detection of epithelial (keratin 18+) and
mesenchymal (vimentin+) cell markers (see Figure S2).
Submerged Cell Culture
When confluence was evident in the well, cells grown from NP
and control NM explants were trypsinized using the Subculture
Reagent Pack (Lonza). These cells were then cultured in 6-well
plates coated with collagen type I using growth media. The culture
was performed in a 5% CO2-humidified atmosphere at 37uC and
the media was changed every 48 h during the submerged culture
(see Figure S1).
Mucociliary Differentiation of Human Nasal Mucosa and
Polyp Epithelial Cells in Air-Liquid Interface (ALI)
After reaching 80–90% subconfluence in the submerged
culture, epithelial cells were subcultured and seeded at a density
of 56104 cells/cm2 onto 0.33 cm2 inserts with polyethylene
terephthalate (PET) transparent membranes for growth of
attachment-dependent cells without matrix (0.4 mm pore size,
24-well, Millipore, Billerica, MA, USA) and incubated at 37uC
supplemented with 5% CO2. Cells were submerged in differen-
tiation media composed of 50% DMEM (Lonza) in BEBM
supplemented with Epidermal Growth Factor (0.5 ng/ml),
Hydrocortisone (0.5 mg/ml), Epinephrine (0.5 mg/ml), Transferrin
(10 mg/ml), Insulin (5 mg/ml), Triiodothyronine (6.5 mg/ml), all-
trans retinoic acid (50 nM), Bovine Pituitary Extract (52 mg/ml),
Gentamicin (30 mg/ml), and Amphotericin B (15 ng/ml) for the
first 7 days.
Cells were then cultured for differentiation for a further 28 days
with the apical surface exposed to air (cell culture in ALI).
Throughout the culture period cells were maintained at 37uC in a
5% CO2 incubator with media changes every 48 hours (see Figure
S1).
Mucociliary differentiation was evaluated at days 0, 7, 14, 21
and 28, corresponding to an initial step (day 0), intermediate steps
of differentiation between step 2 (day 7, undifferentiated pluris-
tratified epithelium) and step 5 (day 28, mature pseudostratified
differentiated epithelium). The following methods were used:
electron microscopy for the ultrastructural study, immunochem-
ical techniques for histological and cell analyses, and enzyme-
linked immunosorbent assay (ELISA) to assess mucous and serous
secretion of cultured epithelia. Additionally, at day 28, cytokine
and chemokine secretion from reconstituted epithelia from NP and
control NM ALI cultures were measured by cytometric bead array
Figure 4. Representative immunocytochemical images of different cell phenotypes in both undifferenciated (day 0) and fully
differentiated (day 28) cultures from both nasal polyp and control nasal mucosa. A, Basal progenitor/stem cells, with positive
immunoreactivity to DNp63. B, Goblet cells, with positive immunoreactivity to MUC5AC. C, Ciliated cells, with positive immunoreactivity to b-tubulin
IV. D, Ciliated cells, marked by b-tubulin IV+ (green), and goblet cells, marked by MUC5B+ (red, arrowheads). Final magnification x400.
doi:10.1371/journal.pone.0100537.g004
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(CBA, BD Biosciences, San Jose, CA, USA) in order to assess NP
inflammatory function compared to control NM.
Ultrastructutal Study by Electron Microscopy
Scanning Electron Microscopy (SEM) and Transmission
Electron Microscopy (TEM) were performed on ALI cultures at
days 0 (initial), 14 (intermediate) and 28 (final step).
For TEM, the cells on inserts were fixed with 3.5%
glutaraldehyde, post-fixed in 1% osmium tetroxide, dehydrated
in a progression of increasing ethanol concentrations up to 100%
ethanol, and embedded in epoxy resin. Thick sections were
obtained and stained with toluidine blue for light microscopy.
Then, ultrathin sections from selected areas were produced by
sectioning with ultramicrotome and collected in copper grids.
Finally, sections were stained with lead citrate and uranyl acetate,
and then examined with the transmission electron microscope,
JEOL 1010 (JEOL, USA), equipped with Bioscans camera (Gatan,
USA) at Scientific-Technical Services at the Faculty of Medicine,
Universitat de Barcelona.
For SEM, the cells on inserts were fixed with 3.5% glutaral-
dehyde, post-fixed in 1% osmium tetroxide, and dehydrated in a
progression of increasing ethanol concentrations up to 100%
ethanol. The samples were then critical-point dried in CO2,
mounted on scanning electron microscope stubs, and sputter-
coated with gold palladium alloy before examination under the
microscope. The surface of ALI cultures were then examined with
a scanning electron microscope, Zeiss DSM 940 A (Zeiss,
Germany).
Preparation of samples and electron microscopy were carried
out at Scientific-Technical Services at the Faculty of Medicine,
Universitat de Barcelona.
Histological Characterization by Immunocytochemistry
To characterize the mucociliary differentiation of NP and
control NM ALI cultures, cells were fixed at different days (0, 7,
14, 21, and 28) with 4% paraformaldehyde in the membranes of
inserts, and these were extracted from the plastic support and
carefully cut in three small pieces for paraffin inclusion (the
membrane pieces were oriented in the paraffin blocks to allow the
obtention of cross sections of the ALI cultures). De-paraffinization
in graded ethanol concentrations and microwave oven antigen
retrieval (350 W, 4–5 min, in pH 6.6 citrate buffer) were
performed on 5 mm sections of paraffin-embedded cell culture.
Subsequently, samples were differentially processed depending on
the detection method used.
For colorimetric detection, the indirect immuno-peroxidase
technique was performed. Samples were blocked with 3%
hydrogen peroxide in order to reduce background staining prior
to incubation overnight at 4uC with primary antibodies, including
mouse monoclonal anti-DNp63 (4A4, Santa Cruz Biotechnology,
Dallas, TX, USA) for basal progenitor/stem cells, mouse
monoclonal anti-MUC5AC (45M1, Thermo Fisher Scientific,
Waltham, MA, USA) for goblet cells, and mouse monoclonal anti-
b-Tubulin IV (clone ONS.1A6, Sigma-Aldrich, St. Louis, MO,
USA) for ciliated cells. Negative controls were performed by
omitting the primary antibody and using a negative control serum
of the same isotype. The EnVision + System-HRP (DAB, Dako,
Glostrup, Denmark), was used for mouse primary antibody
labelling. This was conducted in accordance with the manufac-
turer’s instructions for the purposes of colorimetric detection.
Finally, immunocytochemically-stained sections of NM and NP
ALI cultures were examined with the Olympus BX41 light
microscope (Olympus Corporation, Tokio, Japan), and total and
positive cells were counted in three wells (5 fields from different
areas of each well at 400x magnification) from different nasal
polyp (NP, n = 3) and control nasal mucosa (NM, n = 3) ALI
cultures. The results were subsequently averaged.
For immunofluorescent detection, the cells were permeabilized
with 0.2% Triton X-100 (Sigma-Aldrich Co.) in phosphate
buffered saline, pH 7.4 (PBS, Sigma-Aldrich Co.), at room
temperature, and then blocked with 6% goat serum (Sigma-
Aldrich Co.) for 60 minutes to prevent unspecific binding.
Incubation overnight at 4uC with primary antibodies, including
rabbit polyclonal antibody anti-MUC5B (LUM5B.2) [37] for
goblet cells, and mouse monoclonal anti-b-Tubulin IV (clone
ONS.1A6, Sigma- Aldrich) for ciliated cells, mouse monoclonal
anti-Cytokeratin 18 (Clone DC 10, DAKO) for epithelial cells, and
mouse monoclonal anti-Vimentin (Clone Vim 3B4, DAKO) for
mesenchymal cells. Negative controls were performed by omitting
the primary antibody and using a negative control serum of the
same isotype. Alexa Fluor 488 Goat Anti-Mouse IgG (H+L, green
channel), Alexa Fluor 594 Goat Anti-Mouse IgG (H+L, red
channel), and Alexa Fluor 594 Donkey Anti-rabbit IgG (H+L, red
channel) were used as the secondary antibodies (Invitrogen, Life
Technologies Ltd, UK). The samples were counterstained with
DAPI to identify cell nuclei (blue channel), and the slides were
cover-slipped with ProLong Gold Antifade Reagent (Invitrogen,
Figure 5. Overtime secretion of mucin and lactoferrin in nasal
polyp (black boxes) and control nasal mucosa (white boxes)
ALI cultures. A, MUC5AC secretion (ng/ml). B, MUC5B secretion (RU/
ml). C, Lactoferrin secretion (ng/ml). Results are expressed as medians
and interquartile ranges with 25th–75th percentiles. *, P,0.05 vs day 0.
Statistical analysis by Mann-Whitney U test (between groups) and by
Wilcoxon test (within groups).
doi:10.1371/journal.pone.0100537.g005
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Life Technologies Ltd, UK). Finally, slides were examined with
the Leica DMI6000 B inverted microscope (Leica Microsystems,
Germany).
Measurement of Mucous and Serous Secretion in Apical
Washes
At different times (days 0, 7, 14, 21, and 28), apical surfaces
from NP and control NM ALI cultures were rapidly washed twice
with warmed PBS (500 mL) to mimic nasal lavage, and stored at 2
80uC for further analysis. MUC5AC, MUC5B, and lactoferrin
levels were detected in washing samples by using ELISA. Apical
washings were incubated at 37uC for 90 minutes on MaxiSorp
microtiter 96-well plates (Nunc, Rochester, NY, USA). After
washing with PBS-0.05% Tween-20 (PBS-T, Sigma-Aldrich), wells
were blocked for 1 hour at 37uC with 1% bovine serum albumin
(BSA; Sigma-Aldrich) in PBS-T for MUC5AC, 1% gelatine
(Sigma-Aldrich) in PBS-T for MUC5B, or 6% goat serum in PBS-
T for lactoferrin. After three washes with PBS-T, wells were
sequentially incubated for 1 hour at 37uC with the primary
antibodies: mouse monoclonal anti-MUC5AC (45M1, Thermo
Fisher Scientific), rabbit polyclonal anti-MUC5B (LUM5.B2) [37],
Figure 6. Cytokine and chemokine apical secretion from both nasal polyp (black boxes) and control nasal mucosa (white boxes) ALI
cultures at different days. A, interleukin-8 (IL-8), B, granulocyte-macrophage colony-stimulating factor (GM-CSF), C, eotaxin 1, D, monocyte
chemoattractant protein-1 (MCP-1), E, interleukin-6 (IL-6), and F, interferon-c–induced protein-10 (IP-10), levels in apical washes. Results are expressed
as medians and interquartile ranges with 25th and 75th percentiles. ns, P.0.05 vs day 0 (100%); *, P,0.05 vs day 0. Statistical analysis by Mann-
Whitney U test (between groups) and by Wilcoxon test (within groups).
doi:10.1371/journal.pone.0100537.g006
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and rabbit polyclonal anti-lactoferrin (Abcam, Cambridge, UK).
After washing with PBS-T, samples were incubated for 1 hour at
37uC with HRP-conjugated horse anti-mouse, or HRP-conjugated
goat anti-rabbit antibody (Vector Laboratories, Burlingame, CA,
USA). After washing, 3,39, 5,59-tetramethylbenzidine substrate
(Pierce, Rockford, IL, USA) was added and incubated in the dark
for 15 minutes at room temperature, followed by stop solution (2N
H2SO4) to terminate the reaction. Absorbance was read at
450 nm on a Multiskan EX (Thermo Electron Corporation,
Vantaa, Finland). The relative amount of MUC5AC, MUC5B,
and lactoferrin in each sample was determined from their A450
values using standard curves constructed with serial dilutions of the
commercial mucins from porcine stomach type II (Sigma-Aldrich),
human saliva [38], and lactoferrin from human milk (Sigma-
Aldrich) respectively. Results were expressed as percentages
compared to day 0 (100%) of ALI culture. Sample and standard
duplicates showed a variation rate of ,5%.
Quantitative Analysis of Cytokine and Chemokine
Production
At days 0 (initial), 14 (intermediate) and 28 (final step), apical
surfaces from NP and control NM ALI cultures were rapidly
washed twice with warmed PBS (500 mL) to mimic nasal lavage,
and stored at 280uC for cytometric bead array analysis (CBA) of
different cytokines and chemokines. The Human Inflammatory
Cytokine and Human Chemokine Kits, and GM-CSF and
Eotaxin 1 Flex Sets (BD Biosciences) were used according to the
manufacturer’s instructions to quantitatively measure the following
proteins: interleukin-8 (IL-8), interleukin-1b (IL-1b), interleukin-6
(IL-6), interleukin-10 (IL-10), tumor necrosis factor alfa (TNFa),
and interleukin-12p70 (IL-12p70), RANTES (CCL5/RANTES),
monokine induced by interferon-c (CXCL9/MIG), monocyte
chemoattractant protein-1 (CCL2/MCP-1), and interferon-c–
induced protein-10 (CXCL10/IP-10), eotaxin 1, and granulo-
cyte-macrophage colony-stimulating factor (GM-CSF). Briefly,
50 ml of unknown samples or recombinant standards were added
to 50 ml mixed capture beads and incubated for 3 hours with 50 ml
of phycoerythrin-conjugated detection antibodies (Ab-PE) to form
sandwich complexes. After washing to remove unbound Ab-PE
detection reagent, and acquiring samples on a flow cytometer
FACSArray (BD), results were generated using FCAP Array
software (BD).
Vı´deo Record of Ciliated Cells
AVI video was recorded with an Olympus Fe 5020 camera
connected to light microscopy at 400x magnification (See Video
S1).
Statistical Analysis
Data are reported as median and 25–75th interquartiles, for the
different day analyses, for each cell marker immunocytochemical
outcome (percentages of positive cells from total number of cells),
for MUC5AC (ng/ml), for MUC5B (RU/ml, relative units/ml
was determined relative to standard saliva from one healthy
person), for lactoferrin secretion (ng/ml), and for cytokine and
chemokine production (pg/ml).
The statistical analysis was performed using SigmaPlot Version
10.0 software (Systat, Chicago, IL) and PASW Statistics 18.0 (IBM
Corp., Armonk, NY). The nonparametric Wilcoxon Signed-Ranks
Test was used for paired comparisons (when comparing days 7, 14,
21, 28 vs day 0), and Mann-Whitney U test was used for between-
group comparisons (when comparing NP vs control NM at
different days). Statistical significance was set at p,0.05.
Results
Ultrastructural Study
Mucociliary differentiation process of epithelial cells from both
NP (n = 3) and control NM (n = 3) in the ALI culture was analyzed
by scanning and transmission electron microscopy at days 0, 14,
and 28.
Apical surfaces from both NP and control NM ALI cultures
were observed by scanning electron microscopy (Figure 1). At day
0 apical surfaces showed tightly packed epithelial cells, without
presence of ciliated cells. Whereas at days 14 and 28, apical
surfaces from cultures clearly showed the presence of ciliated cells
in both NP and control NM, as well as the presence of ciliated
cells, with the length of cilia being higher at day 28 than at day 14
(Figure S3, A and B). On the other hand, non-ciliated cells were
showing microvilli on their apical surface at the different analysed
times (Figure S3, A and B).
Ultrastructure of epithelial cells from both NP and control NM
ALI cultures were also examined by transmission electron
microscopy (Figure 2). At day 0, non-polarized epithelial cells
were observed in both NP and control NM cultures, displaying
intercellular spaces between cells, but being connected by
desmosomes and inter-digitations. In addition, neither ciliated
nor goblet cells were observed in both NP and control NM ALI
cultures. In contrast, at days 14 and 28, epithelial cells formed a
pseudostratified, polarized, and fully differentiated epithelium in
both NP and control NM ALI cultures, which included ciliated,
goblet, and basal cells. At days 14 and 28 cells were joined by
apical junctional complexes, formed by tight junctions, adherens
junctions, and desmosomes, showing a tightly packed epithelium
without intercellular spaces (Figure S3, C and D). In both NP and
control NM reconstituted epithelia, ciliated cells were interspersed
with goblet cells and non-ciliated columnar cells, and orientated to
apical side, while basal cells were located at the basal side. Motile
cilia were observed on the apical surface of ciliated cells, attached
to cells by basal bodies, and showing in cross-sections the typical
axonemes, with the latter being composed of central microtubule
singlets in addition to the nine outer doublets (9+2) (Figure S3, E
and F). Goblet cells revealed secretory vesicles, with these being
located along with non-ciliated columnar cells, covered by
microvilli and surrounded by the glycocalix (Figure S3, G and H).
At the ultrastructural level, no differences were found when
comparing NP with control NM ALI cultures.
Histological Characterization
The re-differentiation process from day 0 to day 28 was
characterized by immunocytochemical detection of different cell
phenotypes, at different culture times (0, 7, 14, 21, and 28 days), in
both NP (n = 3) and control NM (n = 3) ALI cultures. Histological
analysis of both culture types showed that, primary epithelial cells
grew from monolayers, including basal progenitor/stem cells
(DNp63+), to form well-differentiated epithelia, including goblet
cells (MUC5AC+), ciliated cells (b-tubulin IV+), and basal
progenitor/stem cells (DNp63+) (Figure 3, A and B).
The number of cells increased significantly (P,0.05) at days 7,
14, 21, and 28, in both NP and control NM cultures compared to
day 0, but without significant differences between both cultures
(Figure S4). Basal progenitor/stem cells (DNp63+, Figure 3, 4A)
were always observed in both NP and control NM cultures,
whereas Goblet cells (MUC5AC+, Figure 3, 4B), and ciliated cells
(b-tubulin IV+, Figure 3, 4C, 4D) were only observed from day 7
and day 14, respectively. Compared to day 0, basal progenitor/
stem cells (DNp63+) were decreased significantly (P,0.05) at days
14, 21, and 28, while goblet cells (MUC5AC+), and ciliated cells
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(b-tubulin IV+) were increased significantly (P,0.05) from day 7
and day 14, respectively (Figure 3B).
Co-immunofluorescence demonstrated that, in both fully
differentiated cultures from both NP and control NM, ciliated
(b-tubulin IV+) and goblet (MUC5B+) cells were clearly present as
distinct cell phenotypes (Figure 4D).
At the cell phenotype level, no significant differences were found
when comparing NP with control NM at 0, 7, 14, 21, or 28 days of
ALI cultures.
Mucous and Serous Secretion
The secretion of MUC5AC, MUC5B, and lactoferrin was
assessed by ELISA in apical washes of both NP (n = 9) and control
NM (n = 7) ALI cultures from day 0 to day 28 (Figure 5).
Compared to day 0, no significant differences were found in
MUC5AC, MUC5B, and lactoferrin, secretions overtime in both
NP and control NM ALI cultures, with the exception of MUC5B
that was significantly (P,0.05) increased in control NM ALI
culture at day 21 (927, 178–1624 RU/ml) compared to day 0
(318, 143–655 RU/ml) (Figure 5B).
At days 7, 14, 21, and 28 of ALI culture, secretions overtime of
MUC5B and lactoferrin, but not MUC5AC, tended to be lower in
NP ALI cultures than in control NM ALI cultures, but without
reaching statistical significance (Figure 5).
Cytokine and Chemokine Production
At days 0, 14, and 28, a number of cytokine (IL-8, IL-1b, IL-6,
IL-10, TNF-a, and IL-12p70) and chemokine (RANTES, MIG,
MCP-1, IP-10, eotaxin-1, and GM-CSF) were analyzed by using
CBA to compare levels in wash samples of the apical surfaces of
NP (n = 9) and control NM (n = 7) ALI cultures. IL-8, IL-6,
eotaxin-1, GM-CSF, IP-10, and MCP-1 were detected in both
epithelial secretions (Figure 6), whereas IL-1b, IL-10, TNF-a, IL-
12p70, RANTES, and MIG were found to be below detection
limit.
Among the detected cytokines and chemokines, during
mucociliar re-differentiation process, at days 0 (initial step) and
14 (intermediate step), no significant differences were found when
comparing NP with control NM ALI cultures (Figure 6). However,
in well-differentiated epithelium, at day 28, the following
differences were found: IL-8 and GM-CSF levels were significantly
(P,0.05) greater in NP apical secretions than in control NM
(Figure 6, A and B); eotaxin-1 and MCP-1 levels had also
increased in apical secretions from NP, but without reaching
statistical significance NM (Figure 6, C and D); and IL-6 and IP-10
levels were similar in NP and control NM epithelia (Figure 6, E
and F).
Discussion
In the present study we have developed and characterized the
mucociliary differentiation over time of human NP epithelial cells
in ALI culture system, compared to control NM. We have
demonstrated: 1st) the mucociliary differentiation of NP epithelial
cells in ALI system was similar to control NM at different analyzed
days (0, 7, 14, 21, and 28); 2nd) NP reconstituted epithelia were
showing similar histological features than control NM reconstitut-
ed epithelia; 3rd) secretion of IL-8 and GM-CSF was significantly
increased in NP compared to control NM reconstituted epithelia,
these findings being in keeping with previous studies [1,20,39].
Overall, our findings provide evidence that 3D in vitro model of NP
reconstituted epithelium maintain an inflammatory function,
assessed by secretion of cytokines and chemokines, which is
characteristic of CRSwNP tissue.
At the initial step of mucociliary differentiation, i.e. day 0 of ALI
culture, we detected in both NP and control NM cultures a
population of basal epithelial stem cells (DNp63+), which decreased
over time. The antibody used (clone 4A1, Santa Cruz) detects the
DN isoform of p63 (DNp63), which has been identified as basal
stem/progenitor cell marker in human [27,40–42] and rodent
[40,41,43,44] tracheobronchial epithelium, as well as in human
nasal epithelium [21,45]. It has been reported that basal stem/
progenitor cells are implicated in the regeneration of human
tracheobronchial [42,46] and nasal [21,45] epithelium. Therefore,
the reconstitution of both NP and control NM epithelia in our ALI
cultures may be attributed, at least in part, to the identified
DNp63+ basal stem/progenitor population. In fact, in both NP
and control NM ALI cultures, DNp63+ cells and undifferentiated
epithelial cells decreased during mucociliary differentiation,
whereas goblet and ciliated cells were seen to be increasing from
day 7 and day 14, respectively. These findings are in accordance
with previous studies describing the mucociliary differentiation of
normal human tracheobronchial [26,29,47] and partly with nasal
[22,23,48] epithelial cells. In our study, neither ciliated nor goblet
cells were observed at day 0 after confluence in both NP and
control NM ALI cultures. In contrast, studies from Yoon et al. [22]
and Kim et al. [23] demonstrated the presence of ciliated and
goblet cells at day 2 after confluence in ALI cultures performed
with normal human nasal epithelial (NHNE) cells. These
differences could be produced by the different origin of cells used,
different techniques and antibodies used for detection of both cell
phenotypes, and the different days analyzed. On the other hand,
comparing NP with control NM ALI cultures, we did not detect
differences in the cell phenotype percentages during mucociliary
differentiation.
In airway mucosa the epithelium acts as physical barrier and
contributes to the innate immune system by secretion of mucus
and antimicrobial peptides [7]. In the present study we have
provided evidence that, in both NP and control NM ALI cultures
at day 0, epithelial cells were connected by desmosomes and inter-
digitations, but not linked by complete apical junctional complex-
es, composed of tight junctions, adherens junctions, and desmo-
somes [49,50]. These cell junctions are multiprotein complexes
that play a role in maintaining the integrity, polarity and
functionality of the airway epithelial barrier [49–52]. Thus,
absence of apical junctional complexes at day 0 suggests that
epithelial cells probably were not apically-basally polarized. In
contrast, at days 14 and 28, epithelial cells were joined by
complete apical junctional complexes and clearly showing an
apically-basally polarized epithelia in both NP and control NM
ALI cultures. On the other hand, we elected to focus on mucins
MUC5AC and MUC5B because they are the two major
components in the mucus of human airways [53,54], and
lactoferrin, due to it being one of the most abundant airway
antimicrobial peptides [7]. Despite not reaching statistical
significance, we found that mucous (MUC5AC and MUC5B)
and serous (lactoferrin) secretions were slightly increased in both
cultures. The increased mucus production during mucociliary
differentiation is probably due to the increased number of goblet
cells, which were expressing both mucins in both cultures. These
findings are partly in keeping with previous studies that have
reported an increased mucin expression during differentiation of
nasal epithelial cells in ALI culture [19,22,48]. On the other hand,
we also observed that MUC5B and lactoferrin secretions tended to
be lower in NP compared to control NM ALI cultures. Since it has
been described that submucosal glands [55,56] and also certain
antimicrobial proteins, most notably lactoferrin [57,58], are
diminished in CRSwNP, our results for the MUC5B and
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lactoferrin secretions could be indicating that there is a glandular
phenotype in control NM ALI cultures, that may be not well
developed during the mucociliar differentiation of NP epithelial
cells. Nevertheless, although we detected decreased levels of
MUC5B and lactoferrin in NP compared to control NM, we are
speculating because differences between both cultures did not
reach statistical significance. Obviously, further studies are
necessary to explore and confirm that epithelial cells have a
glandular phenotype, or even if they are able to form glands, when
cultured at the ALI system.
In contrast to the similarities in mucociliary differentiation of
both NP and control NM ALI cultures, we found relevant
differences associated with inflammatory function of CRSwNP
epithelium, when cytokine (IL-8) and chemokine (GM-CSF)
production were analyzed in well-differentiated epithelium. Our
findings are in keeping with previous studies that have reported the
increase of pro-inflammatory cytokines, such as IL-8 [39,59,60]
and chemokines, as GM-CSF [39,61,62], eotaxin [63], and MCP-
1 [64] in CRSwNP, compared to control nasal mucosa. These
cytokines and chemokines have been implicated in eosinophil
inflammation in nasal polyps [1,39,62,63] and are downregulated
with glucocorticoid [39,62,65,66] or anti-leukotriene [67] treat-
ments. Furthermore, our results from apical washes, particularly
those for IL-8 and GM-CSF, are in keeping with the literature
describing increased levels of pro-inflammatory mediators in nasal
lavages from CRSwNP patients compared to controls [68,69]. The
present study therefore provides direct evidence that fully
differentiated epithelium obtained from NP epithelial cells may
sustain an inflammatory function associated to CRSwNP by
secreting higher levels of cytokines and chemokines than control
NM epithelia.
However, there are limitations to our study. First, some of our
results may be have a low reproducibility due to we detected great
variability, for instance, in the mucus and lactoferrin secretions.
Moreover, the mucociliar differentiation of epithelial cells may
varies between cultures from different donors, different wells, or
even in different areas of the well. For instance, the presence of
ciliated cells varies between different areas of the well. Secondly,
we have not seen in the NP reconstituted epithelium the typical
epithelial alterations of the sinus mucosa from patients with
CRSwNP, where altered epithelium shows goblet or basal cell
hyperplasia, or metaplasia [2]. This could be due, at least in part,
to the absence of inflammatory cells and the release of their
inflammatory mediators in our ALI culture. Exposure of NP ALI
cultures to inflammatory stimuli could potentially induce similar
epithelial alterations as in the sinus mucosa of patients with
CRSwNP. In fact, previous reports have demonstrated that in ALI
cultures from normal human bronchial [70–72] and guinea pig
tracheal [31,73] epithelial cells, the prolonged exposition to IL-13
induces goblet cell hyperplasia in culture. Nevertheless, to our
knowledge, this is the first study demonstrating an elevated
cytokine and chemokine secretion at basal level from NP
reconstituted epithelia in ALI system. It could be relevant because
provide more evidence that, as previously suggested by other
studies [20,21], the 3D in vitro model of NP regenerated epithelium
may be is a good model of the CRSwNP epithelium.
Finally, future studies should investigate the proliferation,
maintainenance, and differentiation of DNp63+ basal cells, which
were identified in our study, and have been recently described as
adult tissue stem cells of nasal epithelium [45]. The biology and
relevance of stem cells in nasal epithelium remain unclear.
Identification of molecular mechanisms of nasal stem cells
involved in repair, proliferation, and mucociliary differentiation
under normal and pathological conditions, provides the potential
for the development of new strategies for CRSwNP treatment.
Conclusion
Reconstituted epithelia from human nasal polyp epithelial cells
cultured in ALI system provides a 3D in vitro model, more
homogeneous, standarized, and reproducible than organotypic
explant cultures, that could be useful for repair and differentiation,
as well as physiopathological, pharmacological, toxicological, and
transport studies (Table 1). Moreover, NP reconstituted epithelium
provides a model that could be useful for studying the role of
epithelium in CRSwNP and for developing new therapeutic
strategies for CRSwNP, including cell therapy.
Supporting Information
Figure S1 Scheme of the different epithelial cell prima-
ry culture steps. Epithelial cells from both nasal mucosa and
nasal polyps were obtained after 5–7 days of explant culture in
appropriate culture medium. During 1 week epithelial cells
proliferate in a regular submerged culture, being then sub-
cultured in inserts where cells were maintained in air-liquid
interface culture for 28 days to obtain a well-differentiated,
polarized, and pseudostratified airway epithelium.
(TIF)
Figure S2 Characterization of human airway epithelial
cells obtained from both control nasal mucosa and nasal
polyp explants. Confirmation of epithelial cell identity and
purity by immunocytochemistry of cytospin preparations using cell
type-specific markers: cytokeratin 18 (green) for epithelial cells and
vimentin (green) for mesenchymal cells. DAPI (blue) was used to
stain cellular nuclei. Epithelial cells isolated from both nasal
mucosa and nasal polyps showed positive immunoreactivity to
cytokeratin 18 (center column) and negative immunoreactivity to
vimentin (right column). Contol cells showed no labeling in the
absence of the primary antibody (left column).
(TIF)
Figure S3 Representative images of ultrastructural
study of nasal polyp ALI culture at days 14 and 28 by
electron microscopy. A–B, Representative images showing
cilia in the apical surfaces by scanning electron microscopy. C–D,
Apical junctional complexes, composed of tight junctions,
adherens junctions, and desmosomes, linking two neighboring
cells by transmission electron microscopy (TEM). E–F, Basal
bodies of motile cilia (showing their typical structure of nine
microtubule triplets) and cross-sections of cilia (showing typical
axonemes, rings of nine outer microtubule doublets with two
central microtubule doublets, 9+2) by TEM. G–H, Microvilia,
glycocalix surrounding microvilli projections, and secretory
granules by TEM.
(TIF)
Figure S4 Epithelial cell counts of nasal polyp and
control nasal mucosa ALI cultures at the different days
analyzed. Cell counts from different nasal polyp (filled circles,
n = 3) and control nasal mucosa (n = 3) ALI cultures. Results are
expressed by dots (media for three replicates of each culture) and
line (median of three different cultures). ns, non-significant,
statistical analysis by Mann-Whitney U test (between groups).
(TIF)
Video S1 Video is showing the synchronized cilia movement of
ciliated cells from a mature and well-differentiated NP epithelium.
This video shows that cilia are not only present in culture but also
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functional. The AVI video was recorded with an Olympus Fe
5020 camera connected to light microscopy and focusing at 400x
magnification.
(AVI)
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